George Song
@Superstring Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$114.248MTotal holdings27
Assets growth rate44.02%Assets growth rate (2-Q avg)-1.76%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Superstring Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 27 positions.
Assets under management
The assets under management (AUM) of Superstring Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 114.248M in assets, with a quarterly growth rate of 44.02% and a 2-quarter average growth rate of -1.76%. The portfolio is managed by George Song, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ETNB89bio Inc
| 3.86% | $4.405M 595,203 shares@ $7.4 avg price | Decreased -12.52% |
NKTXNkarta Inc
| 2.93% | $3.346M 740,294 shares@ $4.53 avg price | Decreased -15.49% |
LEGNLegend Biotech Corp
| 2.59% | $2.949M 60,515 shares@ $48.74 avg price | Decreased -60.87% |
ALLOAllogene Therapeutics Inc
| 1.18% | $1.339M 478,115 shares@ $2.8 avg price | Decreased -30.69% |
SYRESpyre Therapeutics Inc
| 0.96% | $1.097M 37,287 shares@ $29.42 avg price | Decreased -18.17% |
BMEABiomea Fusion Inc
| 0.74% | $843,895 83,554 shares@ $10.1 avg price | Decreased -50% |
TRMLTourmaline Bio Inc
| 0.66% | $748,264 29,104 shares@ $25.72 avg price | Decreased -69.43% |
CABACabaletta Bio Inc
| 0.55% | $622,072 131,795 shares@ $4.72 avg price | Decreased -5.79% |
CRBPCorbus Pharmaceuticals Hldgs
| 0.46% | $524,023 25,401 shares@ $20.64 avg price | Decreased -55.01% |